Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a tailored rehab boost recovery after pancreatic surgery?

NCT ID NCT07768384

Symptom relief Sponsor: IRCCS San Raffaele Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 17, 2026 · Last updated Aug 18, 2026 · Updated 1 time

Summary

This study tests whether a 4-week rehabilitation program is practical and helpful for patients who experience severe complications after pancreatic surgery. The program includes personalized exercise, nutritional guidance, and techniques to reduce anxiety, and can be done at home or in a hospital setting. The goal is to see if patients can stick with the program and whether it aids their physical and mental recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A 4-week multimodal rehabilitation program combining individualized exercise training, nutritional therapy, and anxiety-reducing techniques.
What this could lead to
If successful, this could establish a structured rehab approach to speed recovery and improve quality of life after complicated pancreatic surgery.
What could go wrong
This is a small, early feasibility study, so results may not apply broadly. The program's intensity might be challenging for some patients, and it's unclear if it will improve long-term outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Mar 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

* Inclusion Criteria: * Age ≥18 years. * Patients undergoing elective proximal pancreatic resection (pancreatoduodenectomy or total pancreatectomy). * Patients developing a severe postoperative complication during their hospital stay, defined as a Comprehensive Complication Index (CCI) \>21. * Exclusion Criteria: * Metastatic disease. * Surgical procedures other than pancreatoduodenectomy or total pancreatectomy. * Inability to speak Italian. * Cognitive impairment or illiteracy resulting in inability to read and understand the Italian language. * Medical conditions contraindicating the rehabilitation regimen (exercise and nutritional intervention), including orthopedic or cognitive disabilities and chronic renal failure (dialysis or creatinine \>250 mmol). * Pregnancy.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pancreatic diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

pancreas disorder Postoperative Complications

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pancreatic diseases

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.